R
2.13
0.05 (2.40%)
| Penutupan Terdahulu | 2.08 |
| Buka | 2.14 |
| Jumlah Dagangan | 16,266 |
| Purata Dagangan (3B) | 41,055 |
| Modal Pasaran | 102,246,392 |
| Julat 52 Minggu |
| Margin Operasi (TTM) | -1,146.92% |
| EPS Cair (TTM) | -0.610 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -26.10% |
| Nisbah Semasa (MRQ) | 0.420 |
| Aliran Tunai Operasi (OCF TTM) | -30.92 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -17.07 M |
| Pulangan Atas Aset (ROA TTM) | -85.68% |
| Pulangan Atas Ekuiti (ROE TTM) | -1,073.18% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Health Information Services (US) | Bercampur | Menurun |
| Health Information Services (Global) | Bercampur | Menurun | |
| Stok | Renalytix plc | Bercampur | Bercampur |
AISkor Stockmoo
0.0
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | NA |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 0.0 |
| Purata | 0.00 |
|
Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the common and costly chronic medical conditions globally. The company's product is KidneyIntelX which is being designed to make improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery. |
|
| Sektor | Healthcare |
| Industri | Health Information Services |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 4.51% |
| % Dimiliki oleh Institusi | 4.14% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |